[HTML][HTML] Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease …
R Massoud, N Gagelmann, U Fritzsche-Friedland… - …, 2022 - ncbi.nlm.nih.gov
Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
[HTML][HTML] Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease …
R Massoud, N Gagelmann… - …, 2022 - haematologica.org
Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in …
R Massoud, N Gagelmann… - …, 2022 - pubmed.ncbi.nlm.nih.gov
Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
[PDF][PDF] Comparison of immune reconstitution between anti-T-lymphocyte globulin and post-transplant cyclophosphamide as acute graft-versus-host disease …
R Massoud, N Gagelmann, U Fritzsche-Friedland… - scholar.archive.org
Anti T-cell lymphocyte globulin (ATLG) and post-transplant cyclophosphamide (PTCy) are
now widely used strategies to prevent graft-versus-host disease after allogeneic stem cell …
now widely used strategies to prevent graft-versus-host disease after allogeneic stem cell …
Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease prophylaxis in …
R Massoud, N Gagelmann, U Fritzsche-Friedland… - …, 2022 - europepmc.org
Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
[HTML][HTML] Comparison of immune reconstitution between anti-T-lymphocyte globulin and posttransplant cyclophosphamide as acute graft-versus-host disease …
R Massoud, N Gagelmann… - …, 2022 - haematologica.org
Anti-T-cell lymphocyte globulin (ATLG) and posttransplant cyclophosphamide (PTCy) are
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …
now widely used strategies to prevent graft-versus-host disease (GVHD) after allogeneic …